LNSR Projected Dividend Yield
LENSAR Inc ( NASDAQ : LNSR )LENSAR is a commercial-stage medical device company focused on designing, developing and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Co.'s existing LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining better visual outcomes, efficiency and reproducibility. Co. is also designing, developing, and seeking regulatory clearance of a system, its ALLY Adaptive Cataract Treatment System, which combines an improved femtosecond laser with a phacoemulsification system in a single, integrated cataract treatment system. 20 YEAR PERFORMANCE RESULTS |
LNSR Dividend History Detail LNSR Dividend News LNSR Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |